Oct 1, 2026 07:05AM
Oct 1, 2026 07:05AM
Sep 29, 2026 03:21PM
Sep 29, 2026 07:05AM
Sep 29, 2026 07:05AM
Aug 20, 2026 09:20AM
Aug 13, 2026 06:48AM Unicycive Therapeutics (UNCY) PT Lowered to $25 at Guggenheim
Aug 12, 2026 07:19AM
Jul 6, 2026 08:42AM
Jul 2, 2026 08:45AM
Jul 1, 2026 07:27AM
Jun 30, 2026 07:05AM
Jun 30, 2026 07:05AM
Jun 29, 2026 07:09AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Jun 2, 2026 08:41AM
May 13, 2026 06:51AM
May 12, 2026 07:05AM
Apr 9, 2026 07:05AM
Apr 7, 2026 04:31PM
Apr 6, 2026 08:38AM
Apr 2, 2026 06:43AM Unicycive Therapeutics (UNCY) PT Lowered to $40 at Guggenheim
Mar 30, 2026 07:05AM
Mar 18, 2026 09:17AM
Mar 16, 2026 09:31AM
Mar 12, 2026 08:14AM
Mar 10, 2026 09:08AM
Mar 5, 2026 09:15AM
Feb 17, 2026 09:15AM Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf
Feb 4, 2026 07:05AM
Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM
Jan 29, 2026 07:05AM
Dec 30, 2025 06:36AM
Dec 29, 2025 07:05AM
Dec 29, 2025 07:05AM Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Dec 3, 2025 09:13AM
Dec 2, 2025 12:39PM
Dec 1, 2025 01:41PM
Nov 25, 2025 07:05AM
Nov 14, 2025 09:26AM
Nov 12, 2025 08:36AM
Nov 12, 2025 07:05AM Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Nov 10, 2025 09:42AM
Nov 3, 2025 09:10AM
Nov 3, 2025 07:05AM
Oct 30, 2025 07:05AM
Oct 29, 2025 06:49AM
Oct 28, 2025 07:06AM
Oct 28, 2025 07:05AM Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
Oct 27, 2025 10:31AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All